T
BMY icon

Transce3nd’s Bristol-Myers Squibb BMY Stock Holding History

Transce3nd’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-178
Closed -$8.24K – 272
2025
Q2 		$8.24K Buy
178
+165
+1,269% +$8.1K ﹤0.01% 625
2025
Q1 		$800 Sell
13
-471
-97% -$27.5K ﹤0.01% 982
2024
Q4 		$27.9K Buy
+484
New +$27K 0.01% 488

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Transce3nd's BMY Position: Q3 2025 in Review

Transce3nd sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 178 shares — an estimated $8.24K sold.

Transce3nd first reported a position in BMY in Q4 2024 and held it in 3 quarters. The position peaked at $27.9K in Q4 2024. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Transce3nd reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Transce3nd sold 178 Bristol-Myers Squibb shares in Q3 2025, an estimated $8.24K.
  • Transce3nd first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 3 quarters.
  • Transce3nd's Bristol-Myers Squibb position peaked at $27.9K in Q4 2024.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.